Name | Number of supported studies | Average coverage | |
---|---|---|---|
fibroblast | 18 studies | 36% ± 19% | |
endothelial cell | 11 studies | 29% ± 12% | |
vein endothelial cell | 11 studies | 37% ± 21% | |
connective tissue cell | 10 studies | 42% ± 21% | |
smooth muscle cell | 9 studies | 30% ± 13% | |
pericyte | 7 studies | 29% ± 13% | |
myofibroblast cell | 6 studies | 48% ± 21% | |
ionocyte | 5 studies | 38% ± 5% | |
mesothelial cell | 4 studies | 59% ± 12% | |
endothelial cell of vascular tree | 4 studies | 23% ± 4% | |
capillary endothelial cell | 3 studies | 34% ± 15% | |
endocardial cell | 3 studies | 75% ± 6% | |
basal cell | 3 studies | 24% ± 5% | |
myoepithelial cell | 3 studies | 36% ± 20% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 3 studies | 32% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 97% | 7841.66 | 443 / 459 | 96% | 854.95 | 1070 / 1118 |
stomach | 98% | 8228.50 | 352 / 359 | 65% | 146.12 | 186 / 286 |
skin | 96% | 12068.81 | 1740 / 1809 | 64% | 271.23 | 300 / 472 |
lung | 80% | 5259.11 | 462 / 578 | 79% | 186.07 | 916 / 1155 |
intestine | 87% | 4862.09 | 843 / 966 | 53% | 122.62 | 281 / 527 |
bladder | 81% | 3802.38 | 17 / 21 | 53% | 126.72 | 267 / 504 |
esophagus | 62% | 2908.52 | 903 / 1445 | 57% | 164.87 | 105 / 183 |
uterus | 80% | 3685.51 | 136 / 170 | 29% | 105.10 | 134 / 459 |
kidney | 76% | 4257.78 | 68 / 89 | 28% | 44.25 | 256 / 901 |
adipose | 99% | 10693.53 | 1197 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 16726.43 | 1318 / 1335 | 0% | 0 | 0 / 0 |
thymus | 70% | 2680.54 | 460 / 653 | 26% | 50.52 | 158 / 605 |
pancreas | 2% | 53.27 | 6 / 328 | 87% | 277.44 | 155 / 178 |
heart | 64% | 6151.09 | 554 / 861 | 0% | 0 | 0 / 0 |
prostate | 38% | 1226.50 | 93 / 245 | 17% | 15.97 | 83 / 502 |
tonsil | 0% | 0 | 0 / 0 | 42% | 132.71 | 19 / 45 |
ovary | 11% | 410.86 | 20 / 180 | 30% | 42.90 | 128 / 430 |
lymph node | 0% | 0 | 0 / 0 | 31% | 76.25 | 9 / 29 |
muscle | 27% | 797.53 | 219 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 6% | 114.86 | 16 / 258 | 13% | 30.24 | 29 / 230 |
brain | 0% | 3.89 | 5 / 2642 | 14% | 51.51 | 97 / 705 |
liver | 1% | 14.78 | 2 / 226 | 9% | 10.54 | 37 / 406 |
eye | 0% | 0 | 0 / 0 | 3% | 1.99 | 2 / 80 |
spleen | 0% | 15.07 | 1 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 13.51 | 3 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0032355 | Biological process | response to estradiol |
GO_0071560 | Biological process | cellular response to transforming growth factor beta stimulus |
GO_0071307 | Biological process | cellular response to vitamin K |
GO_0009888 | Biological process | tissue development |
GO_0008593 | Biological process | regulation of Notch signaling pathway |
GO_0001953 | Biological process | negative regulation of cell-matrix adhesion |
GO_0030198 | Biological process | extracellular matrix organization |
GO_0007155 | Biological process | cell adhesion |
GO_0014911 | Biological process | positive regulation of smooth muscle cell migration |
GO_0014850 | Biological process | response to muscle activity |
GO_2000343 | Biological process | positive regulation of chemokine (C-X-C motif) ligand 2 production |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_1990523 | Biological process | bone regeneration |
GO_0003073 | Biological process | regulation of systemic arterial blood pressure |
GO_0001666 | Biological process | response to hypoxia |
GO_1900025 | Biological process | negative regulation of substrate adhesion-dependent cell spreading |
GO_1990138 | Biological process | neuron projection extension |
GO_0009612 | Biological process | response to mechanical stimulus |
GO_0044344 | Biological process | cellular response to fibroblast growth factor stimulus |
GO_0005615 | Cellular component | extracellular space |
GO_0031594 | Cellular component | neuromuscular junction |
GO_0062023 | Cellular component | collagen-containing extracellular matrix |
GO_0031012 | Cellular component | extracellular matrix |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0008201 | Molecular function | heparin binding |
GO_0005201 | Molecular function | extracellular matrix structural constituent |
GO_0046872 | Molecular function | metal ion binding |
GO_0050839 | Molecular function | cell adhesion molecule binding |
GO_0005515 | Molecular function | protein binding |
Gene name | POSTN |
Protein name | Periostin (PN) (Osteoblast-specific factor 2) (OSF-2) |
Synonyms | OSF2 |
Description | FUNCTION: Induces cell attachment and spreading and plays a role in cell adhesion . Enhances incorporation of BMP1 in the fibronectin matrix of connective tissues, and subsequent proteolytic activation of lysyl oxidase LOX (By similarity). . |
Accessions | ENST00000541481.5 [Q15063-6] Q15063 ENST00000379742.4 [Q15063-2] ENST00000541179.5 [Q15063-3] ENST00000379747.9 [Q15063-1] ENST00000379743.8 [Q15063-5] |